🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The open label study is designed to assess the safety and efficacy of 0.05%...
Status
Completed
Location
Park Avenue Dermatology
Start Date
2009-06
Trial ID
NCT00917306
Treatments Being Tested
This study evaluate the efficacy and safety of ingenol mebutate gel 0.015% ...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2015-04
Trial ID
NCT02716714
Treatments Being Tested
The purpose of this study is to determine whether topical application of PE...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2009-07
Trial ID
NCT00942604
Treatments Being Tested
To identify the Maximum Tolerated Dose levels of ingenol mebutate gel after...
Status
Completed
Location
Laser & Skin Surgery Center of Inidana
Start Date
2013-04
Trial ID
NCT01820260
Treatments Being Tested
This trial will be conducted to explore the biological effects in the skin ...
Status
Completed
Location
Universitätsmedizin Göttingen, Georg-August-Universität
Start Date
2011-08
Trial ID
NCT01387711
Treatments Being Tested
The purpose of this study is to determine if the new ingenol derivative gel...
Status
Completed
Location
Dermatology Department
Start Date
2012-11
Trial ID
NCT01703078
Treatments Being Tested
This trial will be conducted to explore the biological effects in the skin ...
Status
Completed
Location
Charité - Universitätsmedizin Berlin
Start Date
2011-09
Trial ID
NCT01449513
Treatments Being Tested
This is a prospective, non-interventional study of adult patients prescribe...
Status
Completed
Location
Office Based Physician
Start Date
2015-12-01
Trial ID
NCT02594436
Treatments Being Tested
The purpose of this study is to determine if the new vehicle formulations c...
Status
Completed
Location
Dermatology Department
Start Date
2013-02
Trial ID
NCT01803477
Treatments Being Tested